An international research group lead by Þórarinn Gíslason, professor at the Faculty of Medicine and chief physician at Landspítali University Hospital, has received 1.3 million US dollars from the National Institute of Health for research in sleep apnea. The grant is for five years.
The aim of the study is to examine how blood pressure response changes with treatment using sleep apnea machines, and whether there are genetic and physiological explanation for variations in individual blood pressure changes in persons with sleep apnea. Furthermore, individual variation in the structure and function of the respiratory tract will be explored using MRI and physiological measurements during sleep.
The total amount of the grant is 11.5 million dollars, thereof 1.3 million dollars go to Iceland. The National Institute of Health has twice before supported the research team's projects. The first grant was for research on genetics and the nature of sleep apnea, and the latter to evaluate the interaction of heart and vascular diseases and sleep apnea. Iceland's share in those two projects was around 2.5 million dollars.
Collaboration on sleep research between the University of Iceland, Landspítali University Hospital and the University of Pennsylvania (PENN) has been in place since 2001. The collaboration is lead by Þórarinn Gíslason, professor at the Faculty of Medicine and chief physician at the pulmonary division at the Landspítali University
Hospital, and Alan I. Pack, professor at the University of Pennsylvania and guest professor at the University of Iceland's Faculty of Medicine.
A seminar was held earlier in June on sleep research in Iceland where future projects of the research team were introduced. Alan I. Pack was the keynote speker and discussed new approaches in medicine with regards to diagnosis and treatment. Hlíf Steingrímsdóttir, managing director of the division of internal medicine at Landspítali University Hospital chaired the event. The seminar was held at Landspítali University Hospital.